News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
161 Results
Type
Article (13)
Press Release (148)
Section
Business (28)
Deals (5)
Drug Development (29)
FDA (2)
Job Trends (2)
News (64)
Policy (1)
Tag
Alliances (2)
Approvals (2)
Best Places to Work (3)
Clinical research (40)
Compensation (1)
C-suite (1)
Data (9)
Diabetes (4)
Earnings (12)
Events (47)
Executive appointments (2)
FDA (5)
Funding (1)
Healthcare (1)
IPO (4)
Mergers & acquisitions (1)
Metabolic disorders (4)
Multiple sclerosis (3)
Neuroscience (3)
Patient recruitment (1)
People (30)
Phase 1 (1)
Phase 2 (16)
Phase 3 (25)
Pipeline (11)
Postmarket research (2)
Regulatory (6)
Date
Last 30 days (1)
Last 365 days (34)
2026 (3)
2025 (33)
2024 (36)
2023 (37)
2022 (12)
2021 (5)
2020 (15)
2019 (3)
2018 (5)
2016 (1)
2015 (2)
2013 (1)
2012 (2)
2011 (3)
2010 (3)
Location
Asia (4)
Australia (1)
California (6)
Europe (133)
Illinois (1)
Massachusetts (1)
New Jersey (1)
North Carolina (1)
Southern California (5)
United States (10)
161 Results for "oculis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
January 6, 2026
·
13 min read
Press Releases
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
November 19, 2025
·
1 min read
Press Releases
Oculis to Participate in Upcoming November 2025 Investor Conferences
November 5, 2025
·
4 min read
Press Releases
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
January 8, 2026
·
12 min read
Press Releases
Oculis Reports Q3 2025 Financial Results and Provides Company Update
November 10, 2025
·
9 min read
Press Releases
Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development
October 30, 2025
·
7 min read
Press Releases
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025
October 14, 2025
·
11 min read
Press Releases
Oculis to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
2 min read
Press Releases
Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
September 22, 2025
·
7 min read
Press Releases
Oculis Reports Q2 2025 Financial Results and Provides Company Update
August 22, 2025
·
9 min read
1 of 17
Next
